Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndrome.

Patil SM, Banker MP, Padalkar RK, Pathak AP, Bhagat SS, Ghone RA, Phatake AS.

J Clin Diagn Res. 2013 May;7(5):804-8. doi: 10.7860/JCDR/2013/5288.2944. Epub 2013 May 1.

2.

Ischemia-modified albumin measured with ultra-filtration assay in early diagnosis of acute coronary syndrome.

Pan SM, Tong CY, Lin Q, Yao CL, Zhao J, Deng Z.

World J Emerg Med. 2010;1(1):37-40.

3.
4.

Ischemia modified albumin: A novel marker for acute coronary syndrome.

Chawla R, Goyal N, Calton R, Goyal S.

Indian J Clin Biochem. 2006 Mar;21(1):77-82. doi: 10.1007/BF02913070.

6.

Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome.

Hess EP, Perry JJ, Calder LA, Thiruganasambandamoorthy V, Body R, Jaffe A, Wells GA, Stiell IG.

Acad Emerg Med. 2010 Apr;17(4):368-75. doi: 10.1111/j.1553-2712.2010.00696.x.

7.

Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.

Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J.

Int J Cardiol. 2004 Nov;97(2):297-301.

PMID:
15458698
8.

Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.

Hjortshøj S, Kristensen SR, Ravkilde J.

Am J Emerg Med. 2010 Feb;28(2):170-6. doi: 10.1016/j.ajem.2008.10.038.

PMID:
20159386
9.

Ischaemia modified albumin in patients with acute coronary syndrome and negative cardiac troponin I.

Sygitowicz G, Janas J, Białek S, Pręgowski J, Pera L, Sitkiewicz D.

Scand J Clin Lab Invest. 2013 Mar;73(2):130-4. doi: 10.3109/00365513.2012.755738. Epub 2013 Jan 17.

PMID:
23327102
10.
12.

Comparative diagnostic accuracy of serum levels of neutrophil activating peptide-2 and pentraxin-3 versus troponin-I in acute coronary syndrome.

Ustündağ M, Orak M, Güloğlu C, Sayhan MB, Alyan O, Kale E.

Anadolu Kardiyol Derg. 2011 Nov;11(7):588-94. doi: 10.5152/akd.2011.160. Epub 2011 Sep 12.

13.

Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study.

Ricci F, Di Scala R, Massacesi C, Di Nicola M, Cremonese G, De Pace D, Rossi S, Griffo I, Cataldo I, Martinotti S, Rotondo D, Jaffe AS, Zimarino M, De Caterina R.

Am J Med. 2016 Jan;129(1):105-14. doi: 10.1016/j.amjmed.2015.06.033. Epub 2015 Jul 11.

15.

Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes.

Bhakthavatsala Reddy C, Cyriac C, Desle HB.

Indian Heart J. 2014 Nov-Dec;66(6):656-62. doi: 10.1016/j.ihj.2014.12.005. Epub 2014 Dec 22.

16.

A synergistic role of ischemia modified albumin and high-sensitivity troponin T in the early diagnosis of acute coronary syndrome.

Mehta MD, Marwah SA, Ghosh S, Shah HN, Trivedi AP, Haridas N.

J Family Med Prim Care. 2015 Oct-Dec;4(4):570-5. doi: 10.4103/2249-4863.174295.

17.

Ischaemia modified albumin in the diagnosis of acute coronary syndromes.

Pantazopoulos I, Papadimitriou L, Dontas I, Demestiha T, Iakovidou N, Xanthos T.

Resuscitation. 2009 Mar;80(3):306-10. doi: 10.1016/j.resuscitation.2008.10.035. Epub 2008 Dec 25. Review.

PMID:
19111377
18.

Comparison of the diagnostic accuracy of ischemia-modified albumin and echocardiography in patients with acute chest pain.

Kountana E, Tziomalos K, Semertzidis P, Dogrammatzi F, Slavakis A, Douma S, Zamboulis C, Geleris P.

Exp Clin Cardiol. 2013 Spring;18(2):98-100.

19.

Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a sensitive troponin I assay.

Body R, Burrows G, Carley S, Lewis PS.

Ann Clin Biochem. 2015 Sep;52(Pt 5):543-9. doi: 10.1177/0004563215576976. Epub 2015 Feb 23.

PMID:
25713467
20.

Malondialdehyde-modified LDL as a marker of acute coronary syndromes.

Holvoet P, Collen D, Van de Werf F.

JAMA. 1999 May 12;281(18):1718-21.

PMID:
10328072

Supplemental Content

Support Center